Oct 22, 2024 8:10 am EDT NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
Oct 8, 2024 8:10 am EDT NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
Sep 23, 2024 6:47 pm EDT NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
Sep 11, 2024 8:05 am EDT NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Aug 29, 2024 8:05 am EDT NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Jun 13, 2024 8:00 am EDT Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
